Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Saturated fat and cardiovascular disease wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Baker Heart and Diabetes Institute wikipedia , lookup
Cardiothoracic surgery wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Coronary artery disease wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Council on Cardiovascular Disease in the Young Strengthening Relationships F or almost a decade, the CVDY Council and the Japanese Society of Pediatric Cardiology and Cardiac Surgery have maintained an ongoing collaboration. Each year, the two groups meet to discuss the latest topics in the field and how their two strategies can best align. MESSAGE FROM THE CHAIR Notably, there are 54 CVDY members who come from Japan. This is the third largest international group within the CVDY Council. Bill Mahle MD, FAHA Bill Mahle, MD, FAHA The JSPCCS was originally formed in 1963 and represented an informal group of interested pediatric cardiologists in Japan. The group has met annually since that time. In 1977, the 20 my.americanheart.org and published in Circulation, including the upcoming update on the Kawasaki disease guidelines as well as the revision of the adult congenital guidelines. The American Heart Association has renewed its emphasis on international membership. There is an international mentoring committee that is available. This is particularly valuable for AHA members from other countries who may lack access to certain superspecialty research or clinical areas. The CVDY and JSPCCS hope to further strengthen ties in the years to come. healthy living is why. For over eight years, Heart Insight has been the award-winning voice of information and inspiration for heart patients and their families with trustworthy guidance for managing your conditions and improving your heart health. Now offered exclusively as a digital publication, Heart Insight is available virtually everywhere. With a new desktop digital edition and FREE apps for all smartphones and tablets — even Kindle — you can have Heart Insight with you wherever you are. Or you can enjoy the magazine on the Heart Insight website. No matter how you choose to read Heart Insight, there is NO subscription fee. Connect and share our stories of survival and tips for living a healthier, longer life. Sign up to receive our monthly e-newsletter as well as notifications about upcoming issues at heart.org/heartinsight Children’s Cardiomyopathy Foundation T he Children’s Cardiomyopathy Foundation (CCF) is pleased to announce the availability of one-year research grants for studies focused on all forms of pediatric cardiomyopathy (Dilated, Hypertrophic, Restrictive, Left Ventricular Non-Compaction or Arrhythmogenic Right Ventricular Cardiomyopathy). The purpose of CCF’s Research Grant Program is to advance knowledge of the basic mechanism of the disease and to develop more accurate diagnostic methods and improved therapies for children affected by cardiomyopathy. Eligibility: Principal investigators must hold an M.D., Ph.D. or equivalent degree, reside in the United States or Canada and have a faculty appointment at an accredited U.S. or Canadian institution. Funding: US $25,000 to US $50,000 for one year of total direct costs. Application Process: CCF requires a letter of intent in advance of the grant application. The 2015 deadline for letters of intent is Friday, June 12 by 5:00 p.m. eastern standard time. Only investigators who have submitted a Letter of Intent and have been invited to submit a formal grant application will be considered for CCF funding. Please visit CCF’s website www. childrenscardiomyopathy.org (click on Research/Grants & Awards) for application guidelines and to view past grant awards. For more information, contact Lisa Yue, founding executive director, at lyue@ childrenscardiomyopathy.org. healthy living for patients, their families & caregivers The Council on Cardiovascular Disease in the Young is proud to announce a new special focus area at Scientific Sessions called Lifelong Congenital Heart Disease and Heart Health in the Young. Stay tuned to scientificsessions.org for CONNECTIONS SPRING 2015 Eleventh International Kawasaki Disease Symposium held Feb. 3-6 in Honolulu: (left to right) Greg Chin, president of the Kawasaki Disease Foundation; program chairs Bryan McCrindle, MD, and Anne Rowley, MD; AHA President Elliott Antman, MD; and Tomisaku Kawasaki, MD. society was named Japanese Research Group of Pediatric Cardiology, and then changed to its current name in 1982 when it became affiliated with the Japan Pediatric Society. The JSPCCS was instrumental in hosting the 1997 Second World Congress of Pediatric Cardiology and Cardiac Surgery, which was originally scheduled to be held in Japan, but was moved following an earthquake. Currently, this society has more than 2,000 members. Seventy-five percent of them are pediatricians, pediatric cardiologists, cardiologists or other medical physicians and 25 percent are cardiovascular surgeons. The group meets annually as a scientific program each summer in July at rotating Japanese locations. The annual scientific meeting always includes a number of international speakers. For almost a decade now, the JSPCCS has reached out to the CVDY Council for collaboration at this summer meeting. There are typically three to five CVDY faculty nominees who participate each summer in this meeting. In addition, the JSPCCS leadership meets with the CVDY leadership at AHA’s Scientific Sessions each year. Notably, there are 54 CVDY members who come from Japan. This is the third largest international group within the CVDY Council. The CVDY and JSPCCS have mapped out a number of future initiatives to further strengthen these ties. The AHA makes an effort to ensure that faculty members from Japan are included each year in Scientific Sessions. Thirty-eight submissions to the pediatric portion of Scientific Sessions come from Japan, and these include both basic science and clinical outcomes. Last year, for example, one of the outstanding abstract presentations came from Dr. Sanos’ group discussing the clinical trial of progenitor cells for hypoplastic left heart syndrome. In addition, the JSPCCS and the CVDY will initiate an exchange program for trainees to allow exposure to unique subspecialties. These will include fields such as Kawasaki disease, stem cell or progenitor cell research or pulmonary hypertension, among other areas. In addition, where possible, the AHA has sought to have input from Japanese experts in relevant statements sponsored by the AHA information as it becomes available. my.americanheart.org 21